We are live on ! Find out more
LNAI

Lunai Bioworks
LNAI

36 hedge funds and large institutions have $3.73M invested in Lunai Bioworks in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

0% less ownership

Funds ownership: 0.09% → 0.09% (-0%)

14% less funds holding

Funds holding: 42 → 36 (-6)

46% less capital invested

Capital invested by funds: $6.87M → $3.73M (-$3.14M)

52% less call options, than puts

Call options by funds: $13K | Put options by funds: $27K

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
36
Holders Change
-6
Holders Change %
-14.29%
% of All Funds
0.58%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
14
Reduced
10
Closed
7
Calls
$13K
Puts
$27K
Net Calls
-$14K
Net Calls Change
-$124K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$58.5K
2
Belvedere Trading
Belvedere Trading
Illinois
+$39.6K
3
Millennium Management
Millennium Management
New York
+$32.9K
4
CF
Cantor Fitzgerald
New York
+$23.2K
5
Northern Trust
Northern Trust
Illinois
+$19.6K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$130K
2
Two Sigma Investments
Two Sigma Investments
New York
-$84.4K
3
Two Sigma Advisers
Two Sigma Advisers
New York
-$55.6K
4
Rafferty Asset Management
Rafferty Asset Management
New York
-$48K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$42K

LNAI Hedge Fund Activity: Q4 2022 in Review

36 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2022, worth a combined $3.73M — down 46% from $6.87M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of LNAI and 2 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 14 added.

The largest buyer was BlackRock, adding an estimated $58.5K. The largest seller was Morgan Stanley, cutting an estimated $130K.

  • 36 institutional investors held Lunai Bioworks (LNAI) as of Q4 2022, down from 42 in Q3 2022.
  • Funds reported $3.73M of Lunai Bioworks stock for Q4 2022, down 46% quarter-over-quarter.
  • 2 funds opened new Lunai Bioworks positions in Q4 2022 and 7 closed out, a net change of -5 holders.
  • The largest Lunai Bioworks buyer in Q4 2022 was BlackRock, an estimated $58.5K added.
  • The largest Lunai Bioworks seller in Q4 2022 was Morgan Stanley, an estimated $130K sold.

Based on aggregated 13F filings for Q4 2022.